Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics
Clinical trial NCT01089283 · UNKNOWN
Trial details
- NCT number
- NCT01089283
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-03-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.